Who are glyceryl nitrate's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Verquvo, Adempas, Inomax, Nitroglycerin, ISDN ointment, Nitroglycerin infusion.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/glyceryl-nitrate.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-13 · How we verify

glyceryl nitrate — Competitive Intelligence Brief

glyceryl nitrate (glyceryl nitrate) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: vasodilator. Area: Cardiovascular.

phase 3 vasodilator guanylate cyclase Cardiovascular Small molecule Live · refreshed every 30 min

Target snapshot

glyceryl nitrate (glyceryl nitrate) — Hvidovre University Hospital. Glyceryl nitrate acts as a vasodilator by releasing nitric oxide, which relaxes vascular smooth muscle and reduces blood pressure.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
glyceryl nitrate TARGET	glyceryl nitrate	Hvidovre University Hospital	phase 3	vasodilator	guanylate cyclase
Verquvo	VERICIGUAT	Merck & Co.	marketed	Soluble Guanylate Cyclase Stimulator [EPC]	Guanylate cyclase soluble subunit beta-1	2021-01-01
Adempas	RIOCIGUAT	Bayer	marketed	Soluble Guanylate Cyclase Stimulator [EPC]	Guanylate cyclase soluble subunit beta-1	2013-01-01
Inomax	NITRIC OXIDE	Vero Biotech Inc	marketed	Standardized Chemical Allergen [EPC]	Soluble guanylate cyclase	1999-01-01
Nitroglycerin	glyceryl trinitrate	Fougera	marketed	Nitrate Vasodilator [EPC]	guanylate cyclase	1981-01-01
ISDN ointment	ISDN ointment	Onze Lieve Vrouwe Gasthuis	marketed	Nitrate vasodilator	Guanylate cyclase (via nitric oxide)
Nitroglycerin infusion	Nitroglycerin infusion	Tri-Service General Hospital	marketed	Nitrate vasodilator	Soluble guanylate cyclase (via nitric oxide)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

2029-03-12 — Nitroglycerin · 7872049 · US
2032-03-11 — Nitroglycerin · 9101592 · US

Sponsor landscape (vasodilator class)

Guangzhou Yipinhong Pharmaceutical CO.,LTD · 1 drug in this class
Hvidovre University Hospital · 1 drug in this class
United States Naval Medical Center, San Diego · 1 drug in this class
yuanli Zhao · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). glyceryl nitrate — Competitive Intelligence Brief. https://druglandscape.com/ci/glyceryl-nitrate. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab